BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19699762)

  • 1. DEBATE (see Elaldi N et al, Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. Journal of Infection 2009; 58: 238-244): Biases and misinterpretation in the assessment of the efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever.
    Ergonul O
    J Infect; 2009 Oct; 59(4):284-6; author reply 286-9. PubMed ID: 19699762
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.
    Elaldi N; Bodur H; Ascioglu S; Celikbas A; Ozkurt Z; Vahaboglu H; Leblebicioglu H; Yilmaz N; Engin A; Sencan M; Aydin K; Dokmetas I; Cevik MA; Dokuzoguz B; Tasyaran MA; Ozturk R; Bakir M; Uzun R
    J Infect; 2009 Mar; 58(3):238-44. PubMed ID: 19246100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran.
    Mardani M; Jahromi MK; Naieni KH; Zeinali M
    Clin Infect Dis; 2003 Jun; 36(12):1613-8. PubMed ID: 12802764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary study to evaluate the effect of intravenous ribavirin treatment on survival rates in Crimean-Congo hemorrhagic fever.
    Cevik MA; Elaldi N; Akinci E; Ongürü P; Erbay A; Buzgan T; Uzun R; Kubar A; Bodur H
    J Infect; 2008 Oct; 57(4):350-1. PubMed ID: 18722669
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever.
    Bodur H; Erbay A; Akıncı E; Öngürü P; Bayazıt N; Eren SS; Kubar A
    Int J Infect Dis; 2011 Jan; 15(1):e44-7. PubMed ID: 21106428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribavirin is not effective against Crimean-Congo hemorrhagic fever: observations from the Turkish experience.
    Ceylan B; Calıca A; Ak O; Akkoyunlu Y; Turhan V
    Int J Infect Dis; 2013 Oct; 17(10):e799-801. PubMed ID: 23773242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribavirin in crimean-congo hemorrhagic fever: primum non nocere.
    Ergönül O; Celikbaş A; Dokuzoğuz B; Eren S; Baykam N; Esener H
    Clin Infect Dis; 2009 Nov; 49(10):1621-2. PubMed ID: 19857172
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethical concern.
    Doganci L
    J Infect; 2009 Oct; 59(4):289-90; author reply 290-1. PubMed ID: 19647019
    [No Abstract]   [Full Text] [Related]  

  • 9. The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study.
    Sharifi-Mood B; Metanat M; Ghorbani-Vaghei A; Fayyaz-Jahani F; Akrami E
    Arch Iran Med; 2009 Mar; 12(2):151-3. PubMed ID: 19249885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early use of ribavirin is beneficial in Crimean-Congo hemorrhagic fever.
    Ozbey SB; Kader Ç; Erbay A; Ergönül Ö
    Vector Borne Zoonotic Dis; 2014 Apr; 14(4):300-2. PubMed ID: 24689859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy.
    Ergönül O; Celikbaş A; Dokuzoguz B; Eren S; Baykam N; Esener H
    Clin Infect Dis; 2004 Jul; 39(2):284-7. PubMed ID: 15307042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of Crimean-Congo haemorrhagic fever successfully treated with therapeutic plasma exchange and ribavirin.
    Kurnaz F; Metan G; Coskun R; Kaynar L; Eser B; Doganay M
    Trop Doct; 2011 Jul; 41(3):181-2. PubMed ID: 21565949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised controlled trial of ribavirin in Crimean Congo haemorrhagic fever: ethical considerations.
    Arda B; Aciduman A; Johnston JC
    J Med Ethics; 2012 Feb; 38(2):117-20. PubMed ID: 21994465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers.
    Ergönül Ö; Keske Ş; Çeldir MG; Kara İA; Pshenichnaya N; Abuova G; Blumberg L; Gönen M
    Emerg Infect Dis; 2018 Sep; 24(9):1642-1648. PubMed ID: 30124196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short report: Crimean-Congo hemorrhagic fever outbreak in Rawalpindi, Pakistan, February 2002.
    Athar MN; Baqai HZ; Ahmad M; Khalid MA; Bashir N; Ahmad AM; Balouch AH; Bashir K
    Am J Trop Med Hyg; 2003 Sep; 69(3):284-7. PubMed ID: 14628945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bradycardia related to ribavirin in four pediatric patients with Crimean-Congo hemorrhagic fever.
    Tezer H; Ozkaya Parlakay A; Gülhan B; Cetin I
    Vector Borne Zoonotic Dis; 2014 Jun; 14(6):464-5. PubMed ID: 24745325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythema nodosum in the course of Crimean-Congo haemorrhagic fever.
    Bijani B; Mardani M; Toosi P
    Trop Doct; 2010 Apr; 40(2):123-4. PubMed ID: 20305115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crimean-Congo hemorrhagic fever.
    Vorou R; Pierroutsakos IN; Maltezou HC
    Curr Opin Infect Dis; 2007 Oct; 20(5):495-500. PubMed ID: 17762783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crimean-Congo hemorrhagic fever.
    Mardani M; Keshtkar-Jahromi M
    Arch Iran Med; 2007 Apr; 10(2):204-14. PubMed ID: 17367225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.
    Koksal I; Yilmaz G; Aksoy F; Aydin H; Yavuz I; Iskender S; Akcay K; Erensoy S; Caylan R; Aydin K
    J Clin Virol; 2010 Jan; 47(1):65-8. PubMed ID: 19962342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.